Yan-feng Xi

Yan-feng Xi


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Pathology - Research and Practice
Verified
Journal Article
Open access
KYKun Yang
Kun Yang
JXJing Xu
Jing Xu
QLQinghang Liu
Qinghang Liu
JLJing Li
Jing Li
YXYan-feng Xi
Yan-feng Xi
Although dose intensification strategies achieve a favorable prognosis for pediatric patients of T-lmphoblastic lymphoma/leukemia (T-LBL/ALL), numerous side effects have been followed. Molecular targeted therapies will be needed to optimize the current treatment strategy for T-LBL/ALL. The aim of this study was to analyse expression and significance of CD47, PD1 and PDL1 in. T-LBL/ALL. We performed immunohistochemistry staining and real time fluorescence quantitative PCR (qRT-PCR) on FFPE tissues. Immunohistochemistry results showed that the high expression rate of CD47 protein was 46.4% (26/56) and the positive expression rate of PDL1 protein was 37.5% (21/56). PD1 expression was observed in tumor infiltrating lymphocytes in approximately 20% of T-LBL/ALL patients, but not expressed on tumor cells of T-LBL/ALL. And the results of qRT-PCR showed that the relative expression levels of CD47, PDL1 and PD1 mRNA in 56 cases of T LBL/ALL were significantly higher than those in control group (6.915 vs 4.050, 12.255 vs 2.575, 37.990 vs 3.615), and the differences were all statistically significant (p all 25 years old. Multivariate Cox regression analysis showed that the high expression of CD47 and PDL1 protein were independent prognostic factors (both p < 0.05). In a word, PD1/PDL1 and CD47 may be involved in the disease progression and prognosis of T-LBL/ALL, and detection and targeting of CD47 and PD1/PDL1 may provide a rational basis to for treatment of T-LBL/ALL.

1 January 2019 in International Journal of Biological Sciences
Verified
Journal Article
Open access
XLXiaoqing Lu
Xiaoqing Lu
RYRui Yang
Rui Yang
LZLichao Zhang
Lichao Zhang
YXYan-feng Xi
Yan-feng Xi
JZJiping Zhao
Jiping Zhao
ZLZhuoyu Li
Zhuoyu Li
Triple negative breast cancer (TNBC) is characterized by aggressive malignant tumor, poor prognosis and lack of targeted treatment. Several studies have established that macrophages are closely associated with the progression of TNBC. Through immunohistochemical analysis, we found that the infiltration of macrophage in TNBC tissue was more than that in non-triple negative breast cancer (nTNBC) tissue. Furthermore, the conditioned medium (CM) of MDA-MB-231 and HCC1937, the TNBC cell lines, had significant migration-promoted effect on macrophages. However, the macrophages migration-promoted ability of nTNBC cell line MCF-7 was weaker than that of MDA-MB-231 and HCC1937 cells. Mechanistically, MDA-MB-231 and HCC1937 cells secreted more macrophage colony-stimulating factor (M-CSF) than MCF-7, which is the main inducer of macrophage migration, and the secreted M-CSF promoted the increase in actin and the elongation of pseudopodia. When M-CSF was neutralized by antibody, the elongation of macrophage pseudopodia was disappeared and the migration was inhibited. In vivo, there were more macrophages in tumors induced by MDA-MB-231 than MCF-7 did. Therefore, M-CSF specially secreted by TNBC was the important cause of macrophages aggregation in TNBC, which further promoted the aggressiveness of TNBC.

3 April 2019 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
WBWenqi Bai
Wenqi Bai
JMJinfeng Ma
Jinfeng Ma
YLYangyang Liu
Yangyang Liu
JLJing Liang
Jing Liang
YWYueqin Wu
Yueqin Wu
YXYan-feng Xi
Yan-feng Xi
Objective: This study aims to screen the MSI detection loci suitable for the East Asian colorectal cancer patients. and explore its intratumoral heterogeneity.Methods: A total of 271 pathological tissues specimens of colorectal cancer were collected. The MSI status was detected using different PCR reagent kits with different detection loci. Then, the results were compared with the immunohistochemical (IHC) staining results. Microdissection of pathological tissues specimens detected to be MSI‐H was performed to examine whether there was intratumoral heterogeneity of MSI status.Results: Thirty‐nine out of 271 cases were dMMR. dMMR occurred mostly in patients with right‐hemi colon cancer (P < 0.0001). Compared with dMMR patients, the clinical stages of pMMR patients were more inclined to be in the late stage with lymph node metastasis (P < 0.0001). MSI‐H tumors were significantly associated with KRAS mutation (P = 0.036) and PD‐L1 expression (P = 0.038). Compared with Promega panel and 24‐locus detection, the consistency between NCI MSI panel and IHC staining results were the highest with the Kappa value of 0.850. The sensitivity of detection decreased from 87.18% to 56.41% with the increase in detection loci. Single locus analysis showed that the first two loci with the highest sensitivity were both mononucleotide loci, namely, BAT‐26 (95.45%) and BAT‐25 (86.36%). The dinucleotide locus with highest sensitivity was D2S123 (50%). The main detection loci of MSI‐H showed no intratumoral heterogeneity.Conclusion: The combination of 2 mononucleotide loci (BAT25, BAT26) and 3 dinucleotide loci (D2S123, D5S346, D17S250) might be the most suitable loci for MSI detection in East Asian population. There is no intratumoral heterogeneity in the main MSI loci.

6 September 2016 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
YXYiRong Xu
YiRong Xu
ZCZhenwen Chen
Zhenwen Chen
Guangheng ZhangGuangheng Zhang
Guangheng Zhang
YXYan-feng Xi
Yan-feng Xi
RSRuiFang Sun
RuiFang Sun
XLXiongFeng Li
XiongFeng Li

9 November 2018 in Oncology Letters
Verified
Journal Article
Open access
PDF file
SZSiyu Zhang
Siyu Zhang
WBWenqi Bai
Wenqi Bai
XTXunan Tong
Xunan Tong
PBPeng Bu
Peng Bu
JXJing Xu
Jing Xu
YXYan-feng Xi
Yan-feng Xi
The tumor microenvironment contributes to the survival and development of tumor cells and is therefore a key target for cancer therapy. The tumor microenvironment has unique physical and chemical properties and is associated with inflammation and immunity. To examine the correlation between tumor microenvironment‑associated factors and the efficacy and prognosis of neoadjuvant therapy for rectal cancer, and to compare the differences between two treatments [neoadjuvant chemotherapy (NAC) vs. neoadjuvant chemoradiotherapy (NACR)], an immunohistochemical method was used to measure the expression levels of CD4+ tumor‑infiltrating lymphocytes (TILs), cluster of differentiation (CD)8+TILs, forkhead box P3 (FOXP3)+TILs, cytotoxic T lymphocyte‑associated antigen‑4+TILs and programmed death ligand‑1 (PD‑L1)+TILs in 109 patients with rectal cancer, pre‑ and post‑neoadjuvant therapy. The significance of these protein expression patterns was also analyzed using tissue microarrays, and the prognostic significance of these findings evaluated. The results indicated that high levels of CD4+TILs, CD8+TILs and PD‑L1+TILs may be associated with favorable responses to neoadjuvant therapy, whereas high levels of FOXP3+TILs were associated with poor therapeutic responses. Expression levels of CD8+TILs and FOXP3+TILs following neoadjuvant therapy were independent prognostic factors and affected the total survival of patients subjected to neoadjuvant therapy for the treatment of rectal cancer. Moreover, the effects of NAC and NACR on the tumor microenvironment may be different.

24 November 2022 in Transplant Immunology
Verified
Journal Article
Closed access
QZQi Zhao
Qi Zhao
YJYu-Meng Jing
Yu-Meng Jing
MHMao-Tao He
Mao-Tao He
LJLi Jing
Li Jing
YXYan-feng Xi
Yan-feng Xi
JZJianzhong Zhang
Jianzhong Zhang